연구성과로 돌아가기

2022 연구자 정보 (741 / 1074)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, Kamyoung
(Kim, K)
Kyungpook Natl Univ, Geog Educ, Daegu, South Korea
Kyungpook Natl Univ, Dept Geog Educ, Daegu, South Korea


[JCR상위 37.9] Modeling Crime Density with Population Dynamics in Space and Time: An Application of Assault in Gangnam, South Korea
Temporal changes in the urban system in South Korea
SSCI
ESCI
37.9 CRIMINOLOGY & PENOLOGY
ENVIRONMENTAL SCIENCES;ENVIRONMENTAL STUDIES;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;URBAN STUDIES
yeondae.jung@utdallas.edu;
ywchun@utdallas.edu;kamyoungkim@knu.ac.kr;
An, Seokyung
(An, S)
Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea
Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
AAT-1785-2020
An, Seokyung

[JCR상위 38.1] Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction SCIE 38.1 CARDIAC & CARDIOVASCULAR SYSTEMS hylee612@snu.ac.kr;
Cho, Hyun-Jai
(Cho, HJ)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul 03080, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Seoul 03080, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea


[JCR상위 38.1] Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates
[JCR상위 36.4] Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
[JCR상위 38.1] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
[JCR상위 42.3] C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
[JCR상위 6.6] In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
[JCR상위 38.1] Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction
[JCR상위 34.0] Impact of Cardiac Troponin Elevation on Mortality of Patients with Acute Heart Failure: Insights from the Korea Acute Heart Failure (KorAHF) Registry
[JCR상위 9.2] A dose-response relationship of renin-angiotensin system blockers and beta-blockers in patients with acute heart failure syndrome: a nationwide prospective cohort study
[JCR상위 42.3] Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (vol 9, 791446, 2022)
[JCR상위 42.3] The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
[JCR상위 29.5] Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy
SCIE 6.6 CARDIAC & CARDIOVASCULAR SYSTEMS
BIOLOGY
CARDIAC & CARDIOVASCULAR SYSTEMS;ENDOCRINOLOGY & METABOLISM
MEDICINE, GENERAL & INTERNAL
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY
MULTIDISCIPLINARY SCIENCES
sangeunlee.md@gmail.com;sangeunlee.md@amc.seoul.kr;
drhyoin.choi@samsung.com;sangeunlee.md@gmail.com;guess124@gmail.com;hylee612@snu.ac.kr;hyunjaicho@snu.ac.kr;jinoh.choi@samsung.com;esjeon@skku.edu;kyungkukhwang@gmail.com;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snu.ac.kr;yubs@yonsei.ac.kr;christiankyehun@hanmail.net;mccho@chungbuk.ac.kr;ohbhmed@snu.ac.kr;jjkim@amc.seoul.kr;
smkang@yuhs.ac;
djchoi@snubh.org;
hylee612@snu.ac.kr;
nurilee.md@gmail.com;jaeycho@chonnam.edu;cvkimkh@gmail.com;medoc7@gmail.com;hyunjaicho@snu.ac.kr;hylee612@snu.ac.kr;eunseok.jeon@samsung.com;jjkim@amc.seoul.kr;mccho@chungbuk.ac.kr;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snubh.org;yubs@yonsei.ac.kr;ohbhmed@snu.ac.kr;
jong.chan.youn@gmail.com;whitesh@catholic.ac.kr;
yubs@yonsei.ac.kr;
Choi, Jin Oh
(Choi, JO)
Sungkyunkwan Univ, Coll Medidne, Seoul, South Korea
Sungkyunkwan Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul 06351, South Korea
D-6140-2017
Choi, Joon

[JCR상위 38.1] Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates
[JCR상위 36.4] Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
SCIE 36.4 CARDIAC & CARDIOVASCULAR SYSTEMS
BIOLOGY
sangeunlee.md@gmail.com;sangeunlee.md@amc.seoul.kr;
drhyoin.choi@samsung.com;sangeunlee.md@gmail.com;guess124@gmail.com;hylee612@snu.ac.kr;hyunjaicho@snu.ac.kr;jinoh.choi@samsung.com;esjeon@skku.edu;kyungkukhwang@gmail.com;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snu.ac.kr;yubs@yonsei.ac.kr;christiankyehun@hanmail.net;mccho@chungbuk.ac.kr;ohbhmed@snu.ac.kr;jjkim@amc.seoul.kr;
Choi, Jin-Oh
(Choi, JO)
Sungkyunkwan Univ, Dept Internal Med, Coll Med, Seoul, South Korea
Sungkyunkwan Univ, Coll Med, Dept Internal Med, Seoul 06351, South Korea
Sungkyunkwan Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Samsung Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea
D-6140-2017
Choi, Joon

[JCR상위 38.1] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
[JCR상위 6.6] In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
[JCR상위 9.2] A dose-response relationship of renin-angiotensin system blockers and beta-blockers in patients with acute heart failure syndrome: a nationwide prospective cohort study
[JCR상위 42.3] Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (vol 9, 791446, 2022)
[JCR상위 42.3] The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
[JCR상위 29.5] Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy
SCIE 6.6 CARDIAC & CARDIOVASCULAR SYSTEMS
CARDIAC & CARDIOVASCULAR SYSTEMS;ENDOCRINOLOGY & METABOLISM
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY
MULTIDISCIPLINARY SCIENCES
smkang@yuhs.ac;
jong.chan.youn@gmail.com;whitesh@catholic.ac.kr;
yubs@yonsei.ac.kr;
Hong, Jung Ae
(Hong, JA)
제1저자 Univ Ulsan, Man Med Ctr, Dept Cardiol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
Univ Ulsan, Man Med Ctr, Dept Cardiovasc Surg, Coll Med, Seoul, South Korea
AAB-2830-2021
Jeong, Gi
0000-0003-3991-7353
Hong, Jung Ae
[JCR상위 38.1] Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates SCIE 38.1 CARDIAC & CARDIOVASCULAR SYSTEMS sangeunlee.md@gmail.com;sangeunlee.md@amc.seoul.kr;
Kim, Kye Hun
(Kim, KH)
Chonnam Natl Univ, Heart Res Ctr, Gwangju, South Korea
Chonnam Natl Univ, Heart Res Ctr, Gwangju 61469, South Korea
Chonnam Natl Univ, Med Sch Hosp, Dept Cardiovasc Med, Gwangju, South Korea
Chonnam Natl Univ, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ, Heart Res Ctr, Dept Internal Med, Gwangju, South Korea
Chonnam Natl Univ, Dept Cardiovasc Med, Med Sch, Gwangju 61469, South Korea
Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju 61469, South Korea
Chonnam Natl Univ, Med Sch, Dept Cardiovasc Med, Gwangju, South Korea
Chonnam Natl Univ Hosp, Coll Med, Dept Internal Med, Div Cardiol, Gwangju, South Korea
Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea

0000-0002-6885-1501
Kim, Kye Hun
[JCR상위 38.1] Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates
[JCR상위 36.4] Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
[JCR상위 55.1] Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: Insight from the Korean Hypertension Cohort Study
[JCR상위 38.1] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
[JCR상위 42.3] C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
[JCR상위 29.7] Predicting survival in heart failure: a risk score based on machine-learning and change point algorithm (vol 110, pg 1321, 2021)
[JCR상위 6.6] In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
[JCR상위 38.1] Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction
[JCR상위 34.0] Impact of Cardiac Troponin Elevation on Mortality of Patients with Acute Heart Failure: Insights from the Korea Acute Heart Failure (KorAHF) Registry
[JCR상위 9.2] A dose-response relationship of renin-angiotensin system blockers and beta-blockers in patients with acute heart failure syndrome: a nationwide prospective cohort study
[JCR상위 42.3] Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (vol 9, 791446, 2022)
[JCR상위 29.5] Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy
[JCR상위 55.9] Optimal blood pressure target in the elderly: rationale and design of the HOW to Optimize eLDerly systolic Blood Pressure (HOWOLD-BP) trial
SCIE 6.6 CARDIAC & CARDIOVASCULAR SYSTEMS
BIOLOGY
PERIPHERAL VASCULAR DISEASE
CARDIAC & CARDIOVASCULAR SYSTEMS;ENDOCRINOLOGY & METABOLISM
MEDICINE, GENERAL & INTERNAL
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY
MULTIDISCIPLINARY SCIENCES
sangeunlee.md@gmail.com;sangeunlee.md@amc.seoul.kr;
drhyoin.choi@samsung.com;sangeunlee.md@gmail.com;guess124@gmail.com;hylee612@snu.ac.kr;hyunjaicho@snu.ac.kr;jinoh.choi@samsung.com;esjeon@skku.edu;kyungkukhwang@gmail.com;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snu.ac.kr;yubs@yonsei.ac.kr;christiankyehun@hanmail.net;mccho@chungbuk.ac.kr;ohbhmed@snu.ac.kr;jjkim@amc.seoul.kr;
ljhmh75@knu.ac.kr;
smkang@yuhs.ac;
djchoi@snubh.org;
woongkook@snu.ac.kr;djchoi@snubh.org;
hylee612@snu.ac.kr;
nurilee.md@gmail.com;jaeycho@chonnam.edu;cvkimkh@gmail.com;medoc7@gmail.com;hyunjaicho@snu.ac.kr;hylee612@snu.ac.kr;eunseok.jeon@samsung.com;jjkim@amc.seoul.kr;mccho@chungbuk.ac.kr;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snubh.org;yubs@yonsei.ac.kr;ohbhmed@snu.ac.kr;
jong.chan.youn@gmail.com;whitesh@catholic.ac.kr;
yubs@yonsei.ac.kr;
mccho@chungbuk.ac.kr;
Kim, Seon-Ok
(Kim, SO)
Univ Ulsan, Man Med Ctr, Dept Clin Epidemiol & Blostat, Coll Med, Seoul, South Korea HGC-7012-2022
KIM, SEON-OK

[JCR상위 38.1] Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates SCIE 38.1 CARDIAC & CARDIOVASCULAR SYSTEMS sangeunlee.md@gmail.com;sangeunlee.md@amc.seoul.kr;
Lee, Chan Joo
(Lee, CJ)
Yonsel Univ, Coll Med, Cardiovasc Res Inst, Severance Cardiovasc Hosp,Div Cardiol,Dept Intern, Seoul 03722, South Korea
Yonsei Univ, Severance Hosp, Cardiovasc Res Inst, Dept Internal Med,Coll Med, 50-1 Yonsei Ro, Ro 03722, Seoul, South Korea
Yonsei Univ, Severance Hosp, Dept Hlth Promot, Coll Med, Seoul, South Korea
AAF-2400-2020
Lee, Jeong Hoon
0000-0002-8756-409X
Lee, Chan Joo
[JCR상위 38.1] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
[JCR상위 6.6] In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
[JCR상위 10.1] Outcome in Patients Treated with Intra-arterial thrombectomy: The optiMAL Blood Pressure control (OPTIMAL-BP) Trial
SCIE 6.6 CARDIAC & CARDIOVASCULAR SYSTEMS
CARDIAC & CARDIOVASCULAR SYSTEMS;ENDOCRINOLOGY & METABOLISM
CLINICAL NEUROLOGY;PERIPHERAL VASCULAR DISEASE
smkang@yuhs.ac;
hsnam@yuhs.ac;
Lee, Hae-Young
(Lee, HY)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul 03080, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Seoul 03080, South Korea
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
JEP-8044-2023
B-1019-2010
Lee, Hye-Young
Lee, Hae
0000-0002-9521-4102
Lee, Hae-Young
[JCR상위 38.1] Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates
[JCR상위 36.4] Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
[JCR상위 55.1] Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: Insight from the Korean Hypertension Cohort Study
[JCR상위 38.1] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
[JCR상위 29.7] Predicting survival in heart failure: a risk score based on machine-learning and change point algorithm (vol 110, pg 1321, 2021)
[JCR상위 6.6] In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
[JCR상위 38.1] Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction
[JCR상위 34.0] Impact of Cardiac Troponin Elevation on Mortality of Patients with Acute Heart Failure: Insights from the Korea Acute Heart Failure (KorAHF) Registry
[JCR상위 9.2] A dose-response relationship of renin-angiotensin system blockers and beta-blockers in patients with acute heart failure syndrome: a nationwide prospective cohort study
[JCR상위 42.3] Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (vol 9, 791446, 2022)
[JCR상위 42.3] The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
[JCR상위 55.9] Optimal blood pressure target in the elderly: rationale and design of the HOW to Optimize eLDerly systolic Blood Pressure (HOWOLD-BP) trial
SCIE 6.6 CARDIAC & CARDIOVASCULAR SYSTEMS
BIOLOGY
PERIPHERAL VASCULAR DISEASE
CARDIAC & CARDIOVASCULAR SYSTEMS;ENDOCRINOLOGY & METABOLISM
MEDICINE, GENERAL & INTERNAL
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY
sangeunlee.md@gmail.com;sangeunlee.md@amc.seoul.kr;
drhyoin.choi@samsung.com;sangeunlee.md@gmail.com;guess124@gmail.com;hylee612@snu.ac.kr;hyunjaicho@snu.ac.kr;jinoh.choi@samsung.com;esjeon@skku.edu;kyungkukhwang@gmail.com;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snu.ac.kr;yubs@yonsei.ac.kr;christiankyehun@hanmail.net;mccho@chungbuk.ac.kr;ohbhmed@snu.ac.kr;jjkim@amc.seoul.kr;
ljhmh75@knu.ac.kr;
smkang@yuhs.ac;
woongkook@snu.ac.kr;djchoi@snubh.org;
hylee612@snu.ac.kr;
nurilee.md@gmail.com;jaeycho@chonnam.edu;cvkimkh@gmail.com;medoc7@gmail.com;hyunjaicho@snu.ac.kr;hylee612@snu.ac.kr;eunseok.jeon@samsung.com;jjkim@amc.seoul.kr;mccho@chungbuk.ac.kr;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snubh.org;yubs@yonsei.ac.kr;ohbhmed@snu.ac.kr;
jong.chan.youn@gmail.com;whitesh@catholic.ac.kr;
mccho@chungbuk.ac.kr;
Lee, Sang Eun
(Lee, SE)
교신저자 Univ Ulsan, Man Med Ctr, Dept Cardiol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Seoul 05505, South Korea
Asan Med Ctr, Div Cardiol, Seoul, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul 05505, South Korea
Asan Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea
Yonsei Univ, Cutaneous Biol Res Inst, Gangnam Severance Hosp, Dept Dermatol,Coll Med, Seoul, South Korea
Yonsei Univ, Gangnam Severance Hosp, Dept Dermatol, Coll Med, Seoul, South Korea
Yonsei Univ, Gangnam Severance Hosp, Cutaneous Biol Res Inst, Coll Med, Seoul, South Korea
L-6920-2013
AAS-3253-2021
LEE, JI
Lee, Sang-Eun
0000-0003-4720-9955
Lee, Sang Eun
[JCR상위 38.1] Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates
[JCR상위 36.4] Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
[JCR상위 38.1] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
[JCR상위 6.6] In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
[JCR상위 38.1] Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction
[JCR상위 9.2] A dose-response relationship of renin-angiotensin system blockers and beta-blockers in patients with acute heart failure syndrome: a nationwide prospective cohort study
[JCR상위 42.3] Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (vol 9, 791446, 2022)
[JCR상위 42.3] The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
[JCR상위 29.5] Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy
[JCR상위 77.9] Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
[JCR상위 77.9] Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea
SCIE 6.6 CARDIAC & CARDIOVASCULAR SYSTEMS
BIOLOGY
CARDIAC & CARDIOVASCULAR SYSTEMS;ENDOCRINOLOGY & METABOLISM
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY
MULTIDISCIPLINARY SCIENCES
DERMATOLOGY
sangeunlee.md@gmail.com;sangeunlee.md@amc.seoul.kr;
drhyoin.choi@samsung.com;sangeunlee.md@gmail.com;guess124@gmail.com;hylee612@snu.ac.kr;hyunjaicho@snu.ac.kr;jinoh.choi@samsung.com;esjeon@skku.edu;kyungkukhwang@gmail.com;scchae@knu.ac.kr;whitesh@catholic.ac.kr;smkang@yumc.yonsei.ac.kr;djchoi@snu.ac.kr;yubs@yonsei.ac.kr;christiankyehun@hanmail.net;mccho@chungbuk.ac.kr;ohbhmed@snu.ac.kr;jjkim@amc.seoul.kr;
smkang@yuhs.ac;
hylee612@snu.ac.kr;
jong.chan.youn@gmail.com;whitesh@catholic.ac.kr;
yubs@yonsei.ac.kr;
drchos@yahoo.co.kr;
drchosh@hotmail.com;
Oh, Gyu Chul
(Oh, GC)
제1저자 Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
Catholic Univ Korea, Coll Med, Catholic Res Inst Intractable Cardiovasc Dis CRID, Seoul, South Korea
AAJ-6530-2021
Oh, Gyu
0000-0003-3056-8791
Oh, Gyu Chul
[JCR상위 38.1] Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction SCIE 38.1 CARDIAC & CARDIOVASCULAR SYSTEMS hylee612@snu.ac.kr;
Oh, Jaewon
(Oh, J)
제1저자 Yonsel Univ, Coll Med, Cardiovasc Res Inst, Severance Cardiovasc Hosp,Div Cardiol,Dept Intern, Seoul 03722, South Korea
Yonsei Univ, Severance Hosp, Cardiovasc Res Inst, Dept Internal Med,Coll Med, 50-1 Yonsei Ro, Ro 03722, Seoul, South Korea

0000-0002-4585-1488
Oh, Jaewon
[JCR상위 38.1] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
[JCR상위 6.6] In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
SCIE 6.6 CARDIAC & CARDIOVASCULAR SYSTEMS
CARDIAC & CARDIOVASCULAR SYSTEMS;ENDOCRINOLOGY & METABOLISM
smkang@yuhs.ac;
Bhadra, B. N.
(Bhadra, BN)
Kyungpook Natl Univ, Dept Chem, DaeHak Ro 80, Daegu 41566, South Korea
Kyungpook Natl Univ, Green Nano Mat Res Ctr, DaeHak Ro 80, Daegu 41566, South Korea
ABG-6935-2021
Bhadra, Biswa
0000-0001-7268-2563
Bhadra, Biswa Nath
[JCR상위 38.2] Tuning the catalytic properties for cycloaddition of CO2 to propylene oxide on zeolitic-imidazolate frameworks through variation of structure and chemical composition SCIE 38.2 CHEMISTRY, PHYSICAL timofeeva@catalysis.ru;sung@knu.ac.kr;
Jhung, S. H.
(Jhung, SH)
교신저자 Kyungpook Natl Univ, Dept Chem, DaeHak Ro 80, Daegu 41566, South Korea
Kyungpook Natl Univ, Green Nano Mat Res Ctr, DaeHak Ro 80, Daegu 41566, South Korea
Kyungpook Natl Univ, Dept Chem, Daegu 702701, South Korea
Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 702701, South Korea
AAO-6683-2021
Jhung, Sung

[JCR상위 38.2] Tuning the catalytic properties for cycloaddition of CO2 to propylene oxide on zeolitic-imidazolate frameworks through variation of structure and chemical composition
[JCR상위 72.2] Particle size effect on the catalytic properties of zeolitic imidazolate frameworks
SCIE 38.2 CHEMISTRY, PHYSICAL
CHEMISTRY, MULTIDISCIPLINARY
timofeeva@catalysis.ru;sung@knu.ac.kr;
timofeeva@catalysis.ru;
페이지 이동: